ATE476656T1 - Verfahren zum nachweis antigenspezifischer oder mitogenaktivierter t-zellen - Google Patents

Verfahren zum nachweis antigenspezifischer oder mitogenaktivierter t-zellen

Info

Publication number
ATE476656T1
ATE476656T1 AT07718589T AT07718589T ATE476656T1 AT E476656 T1 ATE476656 T1 AT E476656T1 AT 07718589 T AT07718589 T AT 07718589T AT 07718589 T AT07718589 T AT 07718589T AT E476656 T1 ATE476656 T1 AT E476656T1
Authority
AT
Austria
Prior art keywords
cells
specific
antigen
mitogen
activated
Prior art date
Application number
AT07718589T
Other languages
English (en)
Inventor
Anthony Kelleher
John Zaunders
Original Assignee
St Vincents Hosp Sydney
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2006901400A external-priority patent/AU2006901400A0/en
Application filed by St Vincents Hosp Sydney filed Critical St Vincents Hosp Sydney
Application granted granted Critical
Publication of ATE476656T1 publication Critical patent/ATE476656T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
    • G01N2333/70514—CD4
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
    • G01N2333/70517—CD8
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30 CD40 or CD95
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70596—Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/715—Assays involving receptors, cell surface antigens or cell surface determinants for cytokines; for lymphokines; for interferons

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT07718589T 2006-03-20 2007-03-20 Verfahren zum nachweis antigenspezifischer oder mitogenaktivierter t-zellen ATE476656T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2006901400A AU2006901400A0 (en) 2006-03-20 A method
PCT/AU2007/000342 WO2007106939A1 (en) 2006-03-20 2007-03-20 A method for detecting antigen-specific or mitogen-activated t cells

Publications (1)

Publication Number Publication Date
ATE476656T1 true ATE476656T1 (de) 2010-08-15

Family

ID=38521945

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07718589T ATE476656T1 (de) 2006-03-20 2007-03-20 Verfahren zum nachweis antigenspezifischer oder mitogenaktivierter t-zellen

Country Status (9)

Country Link
US (1) US8030005B2 (de)
EP (1) EP1996936B1 (de)
JP (1) JP5116756B2 (de)
AT (1) ATE476656T1 (de)
AU (1) AU2007229263B2 (de)
DE (1) DE602007008209D1 (de)
ES (1) ES2349338T3 (de)
HK (1) HK1127120A1 (de)
WO (1) WO2007106939A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090062237A1 (en) * 2007-06-15 2009-03-05 Mayo Foundation For Medical Education And Research Evaluating immune competence
WO2009036521A1 (en) * 2007-09-20 2009-03-26 St Vincent's Hospital Sydney Limited A method for identifying antigen-specific regulatory t cells
KR101361905B1 (ko) * 2008-05-16 2014-02-21 제넨테크, 인크. 베타7 인테그린 길항제를 이용한 위장관 염증 장애의 치료를 평가하기 위한 바이오마커의 용도
WO2013106338A1 (en) 2012-01-12 2013-07-18 Mayo Foundation For Medical Education And Research Detecting latent tuberculosis infections
US9709577B2 (en) * 2012-03-23 2017-07-18 Laboratorios Del Dr. Esteve S.A. Method for monitoring HIV specific T cell responses
JP6059350B2 (ja) * 2012-09-06 2017-01-11 日立化成株式会社 ペプチド特異的免疫の評価のための方法
JP6437522B2 (ja) * 2013-03-15 2018-12-12 ベックマン コールター， インコーポレイテッド フローサイトメトリーにおけるパネル設計のためのシステム及び方法
US10401360B2 (en) 2013-04-29 2019-09-03 Mayo Foundation For Medical Education And Research Flow cytometry assay methods
WO2017040520A1 (en) 2015-08-31 2017-03-09 Hitachi Chemical Co., Ltd. Molecular methods for assessing urothelial disease
GB201605210D0 (en) 2016-03-29 2016-05-11 Oxford Immunotec Ltd Assay
US11806393B2 (en) 2017-02-10 2023-11-07 La Jolla Institute For Allergy And Immunology Flavivirus peptide sequences, epitopes, and methods and uses thereof
WO2018148499A1 (en) * 2017-02-10 2018-08-16 La Jolla Institute For Allergy And Immunology Flavivirus peptide sequences, epitopes, and methods and uses thereof
CN110702918A (zh) * 2019-09-24 2020-01-17 广州迪澳医疗科技有限公司 一种快速检测活动性结核的试剂盒
CN110672500B (zh) * 2019-09-29 2021-11-26 杭州联科生物技术股份有限公司 一种非肝素抗凝血液样本的Th检测方法
CN113252904A (zh) * 2021-05-11 2021-08-13 重庆医科大学附属儿童医院 一种was蛋白的检测方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000011476A1 (en) * 1998-08-25 2000-03-02 The Immune Response Corporation Methods for evaluating immune function
US7651855B2 (en) * 2003-04-17 2010-01-26 The Trustees Of The University Of Pennsylvania Regulatory T cells and their use in immunotherapy and suppression of autoimmune responses

Also Published As

Publication number Publication date
ES2349338T3 (es) 2010-12-30
US8030005B2 (en) 2011-10-04
DE602007008209D1 (de) 2010-09-16
EP1996936A4 (de) 2009-04-01
WO2007106939A1 (en) 2007-09-27
EP1996936A1 (de) 2008-12-03
AU2007229263A1 (en) 2007-09-27
HK1127120A1 (en) 2009-09-18
AU2007229263B2 (en) 2012-08-09
EP1996936B1 (de) 2010-08-04
JP2009529894A (ja) 2009-08-27
US20090221005A1 (en) 2009-09-03
JP5116756B2 (ja) 2013-01-09

Similar Documents

Publication Publication Date Title
ATE476656T1 (de) Verfahren zum nachweis antigenspezifischer oder mitogenaktivierter t-zellen
Dannemiller et al. Combining real-time PCR and next-generation DNA sequencing to provide quantitative comparisons of fungal aerosol populations
HRP20201779T1 (hr) Stanični test za otkrivanje anti-cd3 homodimera
WO2017132279A8 (en) Methods for assaying t-cell dependent bispecific antibodies
MX363201B (es) Procedimiento, matriz y uso para determinar la presencia de cancer pancreatico.
NO20076662L (no) Deteksjon av et malantigen uavhengig av tilstedevaerelse eller fravaer av et korresponderende terapeutisk antistoff
MX2021014947A (es) Métodos para la fabricación de linfocitos t mediante selección celular directa y composiciones de los mismos.
MX2013012143A (es) Inmunoensayo.
ATE501280T1 (de) Verfahren zum nachweis eines analyten in einer biologischen matrix
WO2012075506A3 (en) Methods for predicting and treating infection-induced illnesses and predicting the severity of infection-induced illnesses
WO2008117067A3 (en) Protein signature/markers for the detection of adenocarcinoma
NZ609824A (en) Immunochromatography devices, methods and kits
ES2364314T8 (es) Detección y predicción de preeclampsia.
MX2018013621A (es) Metodo, matriz y uso de estos.
WO2017050939A3 (en) Method and array for diagnosing pancreatic cancer in an individual
WO2009035738A3 (en) Use of antibody secreting cell elispot to assess antibody responses following antigen exposure
MX2019008911A (es) Metodos, matrices y usos de estos.
WO2008073895A3 (en) Methods and devices for testing saliva
ATE526583T1 (de) Immunomagnetische erfassung und abbildung biologischer zielmoleküle
BRPI0513596B8 (pt) método e kit para detectar uma infecção micobacteriana em uma amostra de um indivíduo de interesse por meio da detecção de antígeno micobacteriano
ATE489632T1 (de) Antigennachweis
WO2011003598A3 (de) Detektion von antigenen
ATE522813T1 (de) Verfahren für den nachweis karzinomatöser epithelzellen mittels freigesetzter zytokeratine als marker für diese zellen
MX2012000041A (es) Metodo para someter a prueba a un sujeto que se cree esta predispuesto a tener cancer metastasico usando delta133p53beta.
MX2018015140A (es) Firmas de biomarcadores de lupus eritematoso sistemico y sus usos.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1996936

Country of ref document: EP